파이프라인

Antibody

Monoclonal Antibody

Indication Project code Discovery Non-Clinical Phase I Phase II
Lead CDR optimization &
Candidate
Cell line & Process
development
Cancer APB-A001
Project code Target combinatory
Therapy
Discovery Non-Clinical Phase I Phase II
APB-A001 Chemotherapy
Immunotherapy
Radiotherapy

Bispecific Antibody

Indication Project code Discovery Non-Clinical
(GLP-Toxicity)
Phase I Phase II
Lead Candidate Cell line & Process
development
Cancer APB-B001
APB-B002
TOP